The chlorhexidine gluconate (CHG) dressing market size is projected to be worth USD 952.1 million in 2023. The market is likely to surpass USD 1.5 billion by 2033 at a CAGR of 4.4% during the forecast period. In healthcare settings, there has been a rising emphasis on infection prevention in recent years.
Preventing surgery site infections and other forms of wound infections is important to healthcare practitioners and organisations. Chlorhexidine gluconate dressings are gaining favor as a preventative strategy for wound infection.
In surgical settings, including preoperative skin preparation and postoperative wound care, chlorhexidine gluconate dressings are routinely utilized. They're also used to treat persistent wounds including pressure ulcers, diabetic foot ulcers, and venous leg ulcers. The dressings act as a barrier against germs and aid in the creation of an ideal wound healing environment.
Other Drivers Propelling the Demand for Chlorhexidine Gluconate Dressing include:
Challenges for Companies /Manufacturers in the Chlorhexidine Gluconate Dressing Market:
Opportunities in the Chlorhexidine Gluconate Dressing Industry:
Latest Trends in the Chlorhexidine Gluconate Dressing Market:
| Attributes | Details |
|---|---|
| Chlorhexidine Gluconate Dressing Market Size (2023) | USD 952.1 million |
| Chlorhexidine Gluconate Dressing Market Projected Size (2033) | USD 1.5 billion |
| Value CAGR (2023 to 2033) | 4.4% |
Explore FMI!
Book a free demo
From 2017 to 2022, the global chlorhexidine gluconate dressing market experienced a CAGR of 4.1%, reaching a market size of USD 952.1 million in 2023.
From 2017 to 2022, the global chlorhexidine gluconate dressing industry witnessed steady growth due to its usefulness in preventing and controlling infections in a variety of healthcare settings. While particular market data for chlorhexidine gluconate dressing is not easily available, the wound care market as a whole gives insights into its growth.
The worldwide wound care market has grown significantly during the last decade. The increasing frequency of chronic wounds, greater knowledge about wound care management, developments in wound care technologies, and the need for better infection control techniques are all factors contributing to this rise. These developments are likely to have benefitted chlorhexidine gluconate dressing, which is an essential component of advanced wound care.
Future Forecast for Chlorhexidine Gluconate Dressing Industry:
Looking ahead, the global chlorhexidine gluconate dressing industry is expected to rise at a CAGR of 4.4% from 2023 to 2033. During the forecast period, the market size is expected to reach USD 1.5 billion.
The chlorhexidine gluconate dressing industry is expected to continue its growth trajectory from 2023 to 2033, driven by emphasis on infection prevention and control and increasing prevalence of chronic wounds. Infection prevention and control methods are becoming more important in healthcare systems across the world. Chlorhexidine gluconate dressing is an excellent preventative measure for surgical site infections and healthcare-associated illnesses. The demand for chlorhexidine gluconate dressing is predicted to rise as people become more conscious of the impact of infections on patient outcomes and healthcare expenses.
Due to reasons such as ageing populations, diabetes incidence, and lifestyle changes, the worldwide burden of chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers is predicted to grow. The use of chlorhexidine gluconate dressing in the treatment of chronic wounds is predicted to rise.
| Country | The United States |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 401.3 million |
| CAGR % 2023 to End of Forecast (2033) | 4.5% |
The chlorhexidine gluconate dressing industry in the United States is expected to reach a market size of USD 401.3 million by 2033, expanding at a CAGR of 4.5%. Chlorhexidine gluconate dressings are frequently used in the United States to prevent surgical site infections. The Centers for Disease Control and control (CDC) recommends using these dressings in surgical settings as part of comprehensive infection control programs. This regulation has created high demand for the market in the country.
| Country | The United Kingdom |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 36.6 million |
| CAGR % 2023 to End of Forecast (2033) | 3.9% |
The chlorhexidine gluconate dressing industry in the United Kingdom is expected to reach a market size of USD 36.6 million, expanding at a CAGR of 3.9% during the forecast period. Clinical recommendations from the National Institute for Health and Care Excellence (NICE) in the United Kingdom advocate the use of chlorhexidine gluconate dressings for specific types of wounds, such as surgical wounds, pressure ulcers, and leg ulcers. These rules have an impact on the country's acceptance and use of chlorhexidine gluconate dressing.
| Country | China |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 168.0 million |
| CAGR % 2023 to End of Forecast (2033) | 5.6% |
The chlorhexidine gluconate dressing industry in China is anticipated to reach a market size of USD 168.0 million, moving at a CAGR of 5.6% during the forecast period. Chronic wounds, such as diabetic foot ulcers and venous leg ulcers, affect a large proportion of the Chinese population. Chlorhexidine gluconate dressings are routinely used to prevent infection and enhance healing in these wounds.
| Country | Japan |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 118.2 million |
| CAGR % 2023 to End of Forecast (2033) | 5.4% |
The chlorhexidine gluconate dressing industry in Japan is estimated to reach a market size of USD 118.2 million by 2033, thriving at a CAGR of 5.4%. Japan has been investing in healthcare infrastructure, and the number of hospitals and healthcare institutions has increased significantly. This has resulted in an increase in the use of advanced wound care treatments, such as chlorhexidine gluconate dressings.
| Country | South Korea |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 37.5 million |
| CAGR % 2023 to End of Forecast (2033) | 5.0% |
The chlorhexidine gluconate dressing industry in South Korea is expected to reach a market size of USD 37.5 million, expanding at a CAGR of 5.0% during the forecast period. With a greater emphasis on infection control and patient safety, there is a rising understanding of the need of employing antimicrobial dressings in wound care, such as chlorhexidine gluconate dressings. This awareness has aided in the acceptance of such items in South Korea.
The CHG-impregnated gauze dressings is expected to dominate the chlorhexidine gluconate dressing industry with a CAGR of 4.1% from 2023 to 2033. This segment captures a significant market share in 2023 as it offers various advancements and benefits.
CHG impregnated gauze dressing are designed to provide sustained release of chlorhexidine gluconate, which is broad spectrum antimicrobial agent. This sustained release allows for continuous antimicrobial activity over an extended period. These advancements in infection prevention are gaining the traction for CHG-impregnated gauze dressing.
Transcutaneous electrical nerve stimulation (TENS) is a therapy option for both acute and chronic pain. TENS in combination with a moderate dose of methadone might significantly lessen the severity of withdrawal symptoms, resulting in the high efficiency of TENS to increase demand.
The Surgical Site Infection (SSIs) are expected to dominate the chlorhexidine gluconate dressing industry with a CAGR of 4.7% from 2023 to 2033. SSIs are a significant concern in surgical settings, leading to increased morbidity, prolonged hospital stays, and healthcare cost, CHG dressings are commonly used as part of SSI prevention protocols. The demand for these dressings is driven by the need to reduce the risk of SSIs and improve patient’s outcomes.
The hospital segment is expected to dominate the chlorhexidine gluconate dressing industry with a CAGR of 4.3% from 2023 to 2033. Hospitals prioritize infection prevention measures to reduce the risks of healthcare associated infections. CHG dressings provide against bacteria and other pathogens, helping to prevent infections in wounds or surgical sites. Thus, the priority for infection prevention in the hospitals are aiding the market growth.
The chlorhexidine gluconate dressing sector employ various strategies to stay competitive and maintain their market positions. They invest in research and development to develop advanced dressing technologies, and maintaining the broad product portfolio to address a wider market and meet diverse needs of healthcare providers and patients.
Key Strategies Used by the Participants
Product Development
Companies invest heavily in R&D to deliver novel products that improve efficiency, dependability, and cost-effectiveness. Product innovation allows businesses to differentiate themselves from their competition while also catering to the changing demands of their clients.
Strategic Alliances & Collaborations
Key industry leaders frequently develop strategic partnerships and collaborations with other companies in order to harness their strengths and increase their market reach. Companies might also gain access to new technology and markets through such agreements.
Expansion into Emerging Markets
The chlorhexidine gluconate dressing sector is expanding rapidly in emerging regions such as China and India. Key firms are enhancing their distribution networks and developing local manufacturing facilities to increase their presence in these areas.
Acquisitions and mergers
Mergers and acquisitions are frequently used by key players in the chlorhexidine gluconate dressing business to consolidate their market position, extend their product range, and gain access to new markets.
Key Developments in the Chlorhexidine Gluconate Dressing Market:
The market is valued at USD 952.1 billion in 2023.
Johnson & Johnson, and Avery Dennison Corporation are the key market players.
The global market size is projected to be worth USD 1.5 billion by 2033.
The global rise in surgical procedures drives the market prospects.
The hospitals segment is likely to remain preferred through 2033.
Hyperammonemia Treatment Market Trends – Growth & Therapeutic Advances 2025 to 2035
Veterinary Auto-Immune Therapeutics Market Growth - Trends & Forecast 2025 to 2035
Radial Compression Devices Market Growth - Trends & Forecast 2025 to 2035
Digital Telepathology Market is segmented by Application and End User from 2025 to 2035
Generalized Myasthenia Gravis Management Market - Growth & Treatment Advances 2025 to 2035
Hutchinson-Gilford Progeria Syndrome Market Growth – Innovations & Therapies 2025 to 2035
Chlorhexidine Gluconate Dressing Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
